Literature DB >> 28573609

Ebolavirus: An Overview of Molecular and Clinical Pathogenesis.

Veronica Vine1, Dana P Scott2, Heinz Feldmann3.   

Abstract

Ebolaviruses cause severe, often fatal hemorrhagic fever in Central, East, and West Africa. Until recently, they have been viewed as rare but highly pathogenic infections with regional, but limited, global public health impact. This view has changed with the emergence of the first epidemic of Ebola hemorrhagic fever in West Africa. In this chapter we provide an introduction of the pathogenesis of ebolaviruses as well as a description of clinical disease features. We also describe the current animal models used in ebolavirus research, detailing each model's unique strengths and weaknesses. We focus on Ebola virus representing the type species Zaire ebolavirus of the genus Ebolavirus, as most work relates to this pathogen.

Entities:  

Keywords:  Animal models; Clinical parameters; Ebolavirus; Filovirus; Pathogenesis; Pathophysiology

Mesh:

Year:  2017        PMID: 28573609     DOI: 10.1007/978-1-4939-7116-9_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  An update on ocular complications of Ebola virus disease.

Authors:  Jessica G Shantha; Ian Crozier; Steven Yeh
Journal:  Curr Opin Ophthalmol       Date:  2017-11       Impact factor: 3.761

2.  Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections.

Authors:  Zhengchen Su; Qing Chang; Aleksandra Drelich; Thomas Shelite; Barbara Judy; Yakun Liu; Jie Xiao; Changchen Zhou; Xi He; Yang Jin; Tais Saito; Shaojun Tang; Lynn Soong; Maki Wakamiya; Xiang Fang; Alexander Bukreyev; Thomas Ksiazek; William K Russell; Bin Gong
Journal:  PLoS Negl Trop Dis       Date:  2020-07-20

3.  Ocular complications in Ebola virus disease survivors: the importance of continuing care in West Africa.

Authors:  Duncan E Berry; Alexa L Li; Steven Yeh; Jessica G Shantha
Journal:  Expert Rev Ophthalmol       Date:  2019-06-04

4.  Characterization of Ebola Virus Disease (EVD) in Rhesus Monkeys for Development of EVD Therapeutics.

Authors:  Travis Warren; Elizabeth Zumbrun; Jessica M Weidner; Laura Gomba; Franco Rossi; Roy Bannister; Jacqueline Tarrant; Matthew Reed; Eric Lee; Jo Lynne Raymond; Jay Wells; Joshua Shamblin; Kelly Wetzel; Ginger Donnelly; Sean Van Tongeren; Nicole Lackemeyer; Jesse Steffens; Adrienne Kimmel; Carly Garvey; Holly Bloomfield; Christiana Blair; Bali Singh; Sina Bavari; Tomas Cihlar; Danielle Porter
Journal:  Viruses       Date:  2020-01-13       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.